# A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response

> **NCT05051943** · — · COMPLETED · sponsor: **Fresenius Kabi** · enrollment: 754 (actual)

## Conditions studied

- Crohn Disease
- Ulcerative Colitis
- Psoriasis
- Ankylosing Spondylitis
- Rheumatoid Arthritis
- Psoriatic Arthritis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05051943
- **Lead sponsor:** Fresenius Kabi
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-29
- **Primary completion:** 2023-01-20
- **Final completion:** 2023-01-20
- **Target enrollment:** 754 (ACTUAL)
- **Last updated:** 2023-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05051943

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05051943, "A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05051943. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*